Clinical supply optimization – clarifying the relative risk of change

Case study

The clinical team at this top ten pharmaceutical company struggled with the delicate balancing act between controlling the costs of a major oncology trial and making strategic investments that would pay off in the long term. Read this case study to learn how Thermo Fisher Scientific was able to provide a 25% reduction in shipment volumes over a three month monitored period with no increase in stock outs at the site or depot level saving the sponsor several million dollars in clinical trial supply costs.